Veterinary Microbiome Market Share & Trends Analysis Report, By Product (Phage Therapy Product, Functional Food Application, Gut Health Test kits, Microbial Proteins, Others), By Application (Pathogen Control, Microbiome analysis, Nutrition), By Animal Type, By Region, and Segment Forecasts, 2025-2034
Global Veterinary Microbiome Market Size is valued at USD 6,885.40 Mn in 2024 and is predicted to reach USD 12,060.52 Mn by the year 2034 at a 5.4 % CAGR during the forecast period for 2025-2034.
The term veterinary microbiome refers to the community of microorganisms, including bacteria, viruses, fungi, and other microbes, that reside in and on animals. These microbial populations play a crucial role in digestion, immunity, and disease prevention, making them essential for maintaining animal health. Veterinary microbiome research aims to understand and regulate these microbial communities to enhance the well-being of companion animals, livestock, and other species. Imbalances in the microbiome have been linked to various common disorders in animals, such as diarrhea, stomach pain, gastric inflammation, arthritis, allergies, and food sensitivities, particularly due to the complex microbial interactions within the gastrointestinal (GI) tract.
Increasing awareness among pet owners and livestock producers highlights the importance of maintaining a balanced microbiome for overall health. Scientific research continues to reveal the connection between microbiome imbalances and disease, driving demand for microbiome-based solutions. Additionally, regulatory policies and consumer preferences are shifting toward reducing antibiotic use in animal care, promoting the adoption of natural alternatives like probiotics and postbiotics for disease prevention.
Moreover, advances in microbiome research have also paved the way for customized diets and functional feeds tailored to an animal’s microbiome profile, significantly improving health and performance. As a result, startups and major pet food companies are investing in microbiome-enhancing nutrition, further advancing this rapidly growing field. In January 2024, Novozymes acquired Microbiome Labs, an Illinois-based company specializing in probiotic and microbiome solutions for consumer health. This acquisition strengthened Novozymes’ position in the microbiome industry, expanding its portfolio of innovative probiotic solutions. The gut microbiome plays a crucial role in breaking down food, absorbing nutrients, and producing essential vitamins, contributing to overall digestive health. Beneficial bacteria help maintain a balanced digestive system, preventing issues such as diarrhea, constipation, and bloating.
Additionally, a healthy microbiome supports skin health by reducing inflammation and allergic reactions, as imbalances can lead to conditions like itchy skin, hot spots, or chronic ear infections in pets. In the same month, Kemin Industries launched Enterosure, a probiotic solution designed to control pathogenic bacterial growth in poultry and livestock. This innovative product promotes a healthy microbiome, enhances intestinal resilience, manages gut health challenges, and ultimately improves animal productivity. These developments highlight the increasing importance of microbiome-based solutions in both companion animals and livestock, driving advancements in animal health and nutrition.
Competitive Landscape
Some of the Major Key Players in the Veterinary Microbiome Market are
• Adisseo
• Alltech
• AnimalBiome
• BaseClear BV
• Biorigin
• CanBiocin
• Cargill, Incorporated
• Chr. Hansen Holding A/S
• Cytophage Technologies Ltd
• DSM
• Evonik Industries AG
• Hill's Pet Nutrition, Inc.
• Kemin Industries Inc
• Lallemand Inc.
• Land O'Lakes
• Leiber
• MicroSintesis Inc.
• NomNomNow Inc.
• Novozymes
• Novus International, Inc.
• Orion Corporation
• Pando Nutrition Inc.
• Petivity
• PhageLab
• Phibro Animal Health Corporation
• Phileo (Lesaffre)
• Porcinotec Co., Ltd.
• Proteon Pharmaceuticals S.A.
Market Segmentation
The veterinary microbiome market is segmented based on the by-product, application and, animal type. Based on the product, the market is divided into phage therapy products, functional food applications, gut health test kits, microbial proteins, and others. Based on the Application, the market is divided into pathogen control, microbiome analysis, and nutrition. Based on the animal type, the market is divided into companion animals, poultry, ruminants, swine, aquaculture, and others. Based on the Companion animals, the segment is divided into dogs and cats.
The Functional Food Segment is Expected to Have the Highest Growth Rate During the Forecast Period
Based on the product, the market is divided into phage therapy products, functional food applications, gut health test kits, microbial proteins, and others. Among these, the functional food segment is expected to have the highest growth rate during the forecast period. The functional food segment is divided into probiotics, prebiotics, and postbiotics. Pet owners and livestock producers increasingly recognize the gut microbiome's vital role in digestion, immunity, and overall health. Scientific studies link microbiome imbalances to various diseases, driving demand for functional foods that support gut health. Growing concerns over antibiotic resistance have led to regulatory changes and consumer pressure to reduce antibiotic use in animal feed. As a natural alternative, probiotics and prebiotics help promote beneficial gut bacteria and prevent infections without relying on antibiotics. With a rising preference for natural, non-pharmaceutical solutions, functional foods offer preventive care, minimizing the need for medications and veterinary interventions.
The Poultry Segment Dominates the Market
Based on the animal type, the market is divided into companion animals, poultry, ruminants, swine, aquaculture, and others. Based on the Companion animals, the segment is divided into dogs and cats. Among these, the poultry segment dominates the market. Poultry is one of the most widely consumed meats worldwide, creating a strong demand for sustainable and efficient production. A healthy microbiome plays a crucial role in enhancing growth rates, improving feed conversion efficiency, and boosting overall productivity, making microbiome solutions essential for the poultry industry. To support gut health and disease prevention, poultry producers are increasingly incorporating probiotics, prebiotics, and postbiotics into feed formulations. These microbiome-enhancing additives help strengthen gut integrity, reduce pathogenic bacteria, and optimize bird performance. Additionally, companies and research institutions are investing in the development of species-specific probiotics and microbiome-based vaccines, further advancing poultry health and production efficiency.
Asia Pacific Has the Largest Market Share During the Forecast Period.
The Asia-Pacific region dominates the veterinary microbiome market due to its large livestock and poultry population, increasing meat consumption, rising demand for antibiotic-free animal products, and advancements in microbiome research and biotechnology. Rising pet ownership in urban areas of China, Japan, India, and South Korea is increasing the demand for microbiome-based pet food, probiotics, and digestive health solutions. Pet food companies in Asia-Pacific are incorporating microbiome-enhancing ingredients to cater to health-conscious pet owners. Major animal health companies and biotech firms are expanding their presence in Asia-Pacific to tap into the growing microbiome market.
Recent Developments:
• In October 2024, Lesaffre performed the acquisition of a majority stake in Biorigin, a business unit of Zilor, a multinational company producing yeast derivative products, to enhance the supply of yeast derivatives for savory ingredients. The cooperation will improve production processes, logistics, and services to the benefit of a global customer base.
• In Sept 2023, CareVet, a prominent network of veterinary hospitals, collaborated with Blendvet and Hill's Pet Nutrition to incorporate diversity, equity, inclusion, and belonging (DEIB) content into its comprehensive Learning Management System, CareVet Learning Institute. This innovative effort sought to enhance workplace environments by promoting inclusivity and a sense of belonging for teams, clients, and the community.
Veterinary Microbiome Market Report Scope
| Report Attribute | Specifications |
| Market Size Value In 2024 | USD 6,885.40 Mn |
| Revenue Forecast In 2034 | USD 12,060.52 Mn |
| Growth Rate CAGR | CAGR of 5.4 % from 2025 to 2034 |
| Quantitative Units | Representation of revenue in US$ Mn,and CAGR from 2025 to 2034 |
| Historic Year | 2021 to 2024 |
| Forecast Year | 2025-2034 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Product, Application, Animal Type |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South Korea; Southeast Asia |
| Competitive Landscape | Adisseo, Alltech, AnimalBiome, BaseClear BV, Biorigin, CanBiocin, Cargill, Incorporated, Chr. Hansen Holding A/S, Cytophage Technologies Ltd, DSM, Evonik Industries AG, Hill's Pet Nutrition, Inc., Kemin Industries Inc, Lallemand Inc., Land O'Lakes, Leiber, MicroSintesis Inc., NomNomNow Inc., Novozymes, Novus International, Inc., Orion Corporation, Pando Nutrition Inc., Petivity, PhageLab, Phibro Animal Health Corporation, Phileo (Lesaffre), Porcinotec Co., Ltd., Proteon Pharmaceuticals S.A. |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing And Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Segmentation of Veterinary Microbiome Market
Global Veterinary Microbiome Market- By Product
• Phage Therapy Product
• Functional Food
o Probiotics
o Prebiotics
o Postbiotics
• Gut Health Test kits
• Microbial Proteins
• Others
Global Veterinary Microbiome Market By Application
• Pathogen Control
• Microbiome analysis
• Nutrition
Global Veterinary Microbiome Market – Animal Type
• Companion animals
o Dogs
o Cats
• Poultry
• Ruminants
• Swine
• Aquaculture
• Others
Global Veterinary Microbiome Market – By Region
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
Adisseo, Alltech, AnimalBiome, BaseClear BV, Biorigin, CanBiocin, Cargill, Incorporated, Chr. Hansen Holding A/S, Cytophage Technologies Ltd, DSM, Evo
Veterinary Microbiome Market Size is valued at USD 6,885.40 Mn in 2024 and is predicted to reach USD 12,060.52 Mn by the year 2034
Veterinary Microbiome Market is expected to grow at a 5.4 % CAGR during the forecast period for 2025-2034.
Veterinary microbiome market is segmented based on the by-product, application and, animal type.
Asia Pacific region is leading the Veterinary Microbiome Market.